JPH05501949A - 発現ベクターのマルチコピー組込みにより形質転換した真菌による蛋白質の製法 - Google Patents
発現ベクターのマルチコピー組込みにより形質転換した真菌による蛋白質の製法Info
- Publication number
- JPH05501949A JPH05501949A JP2511191A JP51119190A JPH05501949A JP H05501949 A JPH05501949 A JP H05501949A JP 2511191 A JP2511191 A JP 2511191A JP 51119190 A JP51119190 A JP 51119190A JP H05501949 A JPH05501949 A JP H05501949A
- Authority
- JP
- Japan
- Prior art keywords
- gene
- lipase
- dna
- host
- promoter
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000623 proteins and genes Proteins 0.000 title claims description 194
- 230000010354 integration Effects 0.000 title claims description 103
- 102000004169 proteins and genes Human genes 0.000 title claims description 60
- 238000004519 manufacturing process Methods 0.000 title claims description 40
- 239000013604 expression vector Substances 0.000 title claims description 30
- 241000233866 Fungi Species 0.000 title claims description 11
- 108090001060 Lipase Proteins 0.000 claims description 166
- 102000004882 Lipase Human genes 0.000 claims description 120
- 239000004367 Lipase Substances 0.000 claims description 117
- 235000019421 lipase Nutrition 0.000 claims description 115
- 239000013598 vector Substances 0.000 claims description 107
- 108020004414 DNA Proteins 0.000 claims description 94
- 210000004027 cell Anatomy 0.000 claims description 87
- 238000000034 method Methods 0.000 claims description 82
- 108090000790 Enzymes Proteins 0.000 claims description 53
- 102000004190 Enzymes Human genes 0.000 claims description 52
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 52
- 229940088598 enzyme Drugs 0.000 claims description 52
- 238000012217 deletion Methods 0.000 claims description 43
- 230000037430 deletion Effects 0.000 claims description 43
- 150000001413 amino acids Chemical group 0.000 claims description 38
- 239000002609 medium Substances 0.000 claims description 37
- 239000000203 mixture Substances 0.000 claims description 32
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 28
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims description 27
- 239000003550 marker Substances 0.000 claims description 27
- 230000012010 growth Effects 0.000 claims description 25
- 230000015572 biosynthetic process Effects 0.000 claims description 23
- 235000020774 essential nutrients Nutrition 0.000 claims description 23
- 239000002773 nucleotide Substances 0.000 claims description 23
- 125000003729 nucleotide group Chemical group 0.000 claims description 23
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 22
- 238000000855 fermentation Methods 0.000 claims description 21
- 230000004151 fermentation Effects 0.000 claims description 21
- 241000206602 Eukaryota Species 0.000 claims description 20
- 108010076504 Protein Sorting Signals Proteins 0.000 claims description 18
- 210000000349 chromosome Anatomy 0.000 claims description 14
- 239000003599 detergent Substances 0.000 claims description 14
- 229940041514 candida albicans extract Drugs 0.000 claims description 13
- 239000012138 yeast extract Substances 0.000 claims description 13
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 claims description 12
- 238000003786 synthesis reaction Methods 0.000 claims description 12
- 230000001976 improved effect Effects 0.000 claims description 8
- 230000028327 secretion Effects 0.000 claims description 8
- 108020001027 Ribosomal DNA Proteins 0.000 claims description 7
- 102100039555 Galectin-7 Human genes 0.000 claims description 6
- 108060003951 Immunoglobulin Proteins 0.000 claims description 6
- 238000006243 chemical reaction Methods 0.000 claims description 6
- 239000001963 growth medium Substances 0.000 claims description 6
- 102000018358 immunoglobulin Human genes 0.000 claims description 6
- 238000006467 substitution reaction Methods 0.000 claims description 6
- 229940035893 uracil Drugs 0.000 claims description 6
- 235000013343 vitamin Nutrition 0.000 claims description 6
- 239000011782 vitamin Substances 0.000 claims description 6
- 229940088594 vitamin Drugs 0.000 claims description 6
- 229930003231 vitamin Natural products 0.000 claims description 6
- 102000053602 DNA Human genes 0.000 claims description 5
- 230000006696 biosynthetic metabolic pathway Effects 0.000 claims description 5
- 102100031181 Glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 claims description 4
- 108090000854 Oxidoreductases Proteins 0.000 claims description 4
- 102000004316 Oxidoreductases Human genes 0.000 claims description 4
- 239000005862 Whey Substances 0.000 claims description 4
- 102000007544 Whey Proteins Human genes 0.000 claims description 4
- 108010046377 Whey Proteins Proteins 0.000 claims description 4
- 238000010353 genetic engineering Methods 0.000 claims description 4
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 claims description 4
- 230000037361 pathway Effects 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 4
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims description 3
- 241000235648 Pichia Species 0.000 claims description 3
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 3
- 229940072221 immunoglobulins Drugs 0.000 claims description 3
- 235000013379 molasses Nutrition 0.000 claims description 3
- 108020004418 ribosomal RNA Proteins 0.000 claims description 3
- 239000006152 selective media Substances 0.000 claims description 3
- 230000000392 somatic effect Effects 0.000 claims description 3
- 101100074137 Arabidopsis thaliana IRX12 gene Proteins 0.000 claims description 2
- 108010059892 Cellulase Proteins 0.000 claims description 2
- 239000004366 Glucose oxidase Substances 0.000 claims description 2
- 108010015776 Glucose oxidase Proteins 0.000 claims description 2
- 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 claims description 2
- 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 claims description 2
- 102000013463 Immunoglobulin Light Chains Human genes 0.000 claims description 2
- 108010065825 Immunoglobulin Light Chains Proteins 0.000 claims description 2
- 101150022713 LAC4 gene Proteins 0.000 claims description 2
- 230000000035 biogenic effect Effects 0.000 claims description 2
- 229940106157 cellulase Drugs 0.000 claims description 2
- 230000037029 cross reaction Effects 0.000 claims description 2
- 229940116332 glucose oxidase Drugs 0.000 claims description 2
- 235000019420 glucose oxidase Nutrition 0.000 claims description 2
- 230000003301 hydrolyzing effect Effects 0.000 claims description 2
- 108010090785 inulinase Proteins 0.000 claims description 2
- 108020004707 nucleic acids Proteins 0.000 claims description 2
- 102000039446 nucleic acids Human genes 0.000 claims description 2
- 150000007523 nucleic acids Chemical class 0.000 claims description 2
- 241000228212 Aspergillus Species 0.000 claims 3
- 241000235070 Saccharomyces Species 0.000 claims 3
- 241000223259 Trichoderma Species 0.000 claims 3
- 241000235649 Kluyveromyces Species 0.000 claims 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 2
- 229910052760 oxygen Inorganic materials 0.000 claims 2
- 239000001301 oxygen Substances 0.000 claims 2
- 241000588986 Alcaligenes Species 0.000 claims 1
- 101710093617 Dihydroxyacetone synthase Proteins 0.000 claims 1
- 101000887163 Gallus gallus Gallinacin-4 Proteins 0.000 claims 1
- 101000887166 Gallus gallus Gallinacin-7 Proteins 0.000 claims 1
- 102000006496 Immunoglobulin Heavy Chains Human genes 0.000 claims 1
- 108010019476 Immunoglobulin Heavy Chains Proteins 0.000 claims 1
- 241000235061 Pichia sp. Species 0.000 claims 1
- 241000589540 Pseudomonas fluorescens Species 0.000 claims 1
- 241000235527 Rhizopus Species 0.000 claims 1
- 244000292604 Salvia columbariae Species 0.000 claims 1
- 235000012377 Salvia columbariae var. columbariae Nutrition 0.000 claims 1
- 235000001498 Salvia hispanica Nutrition 0.000 claims 1
- 150000007513 acids Chemical class 0.000 claims 1
- 230000008238 biochemical pathway Effects 0.000 claims 1
- 239000003054 catalyst Substances 0.000 claims 1
- 235000014167 chia Nutrition 0.000 claims 1
- 230000002950 deficient Effects 0.000 claims 1
- 235000015097 nutrients Nutrition 0.000 claims 1
- PVFDPMYXCZLHKY-MLLWLMKGSA-M sodium [(1R,2R,4aR,8aS)-2-hydroxy-5-[(2E)-2-[(4S)-4-hydroxy-2-oxooxolan-3-ylidene]ethyl]-1,4a,6-trimethyl-2,3,4,7,8,8a-hexahydronaphthalen-1-yl]methyl sulfate Chemical compound [Na+].C([C@@H]1[C@](C)(COS([O-])(=O)=O)[C@H](O)CC[C@]11C)CC(C)=C1C\C=C1/[C@H](O)COC1=O PVFDPMYXCZLHKY-MLLWLMKGSA-M 0.000 claims 1
- 239000012634 fragment Substances 0.000 description 125
- 239000013612 plasmid Substances 0.000 description 100
- 230000014509 gene expression Effects 0.000 description 59
- 235000018102 proteins Nutrition 0.000 description 51
- 108010030291 alpha-Galactosidase Proteins 0.000 description 47
- 102000005840 alpha-Galactosidase Human genes 0.000 description 39
- 238000010276 construction Methods 0.000 description 27
- 239000000523 sample Substances 0.000 description 22
- 238000010586 diagram Methods 0.000 description 19
- 238000002474 experimental method Methods 0.000 description 18
- 238000009396 hybridization Methods 0.000 description 18
- 235000001014 amino acid Nutrition 0.000 description 17
- 229940024606 amino acid Drugs 0.000 description 17
- 108091008146 restriction endonucleases Proteins 0.000 description 17
- 241000588724 Escherichia coli Species 0.000 description 15
- 108091005804 Peptidases Proteins 0.000 description 14
- 239000004365 Protease Substances 0.000 description 14
- 244000005700 microbiome Species 0.000 description 14
- 230000035772 mutation Effects 0.000 description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 108010051210 beta-Fructofuranosidase Proteins 0.000 description 11
- 239000000499 gel Substances 0.000 description 11
- 230000002068 genetic effect Effects 0.000 description 11
- 239000001573 invertase Substances 0.000 description 11
- 235000011073 invertase Nutrition 0.000 description 11
- 108091034117 Oligonucleotide Proteins 0.000 description 10
- 102000035195 Peptidases Human genes 0.000 description 10
- 238000004458 analytical method Methods 0.000 description 10
- 230000029087 digestion Effects 0.000 description 10
- 239000002502 liposome Substances 0.000 description 10
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 9
- 239000011543 agarose gel Substances 0.000 description 9
- 238000009585 enzyme analysis Methods 0.000 description 9
- 239000008103 glucose Substances 0.000 description 9
- 108090000765 processed proteins & peptides Proteins 0.000 description 9
- 229920001817 Agar Polymers 0.000 description 8
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
- 244000303965 Cyamopsis psoralioides Species 0.000 description 8
- 239000008272 agar Substances 0.000 description 8
- 239000013611 chromosomal DNA Substances 0.000 description 8
- 238000010367 cloning Methods 0.000 description 8
- 238000003780 insertion Methods 0.000 description 8
- 230000037431 insertion Effects 0.000 description 8
- 102000004196 processed proteins & peptides Human genes 0.000 description 8
- 241000894007 species Species 0.000 description 8
- 239000006137 Luria-Bertani broth Substances 0.000 description 7
- 108020004511 Recombinant DNA Proteins 0.000 description 7
- 101150050575 URA3 gene Proteins 0.000 description 7
- 125000000539 amino acid group Chemical group 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 229920001184 polypeptide Polymers 0.000 description 7
- 230000009466 transformation Effects 0.000 description 7
- 238000011144 upstream manufacturing Methods 0.000 description 7
- 241000894006 Bacteria Species 0.000 description 6
- 108020004705 Codon Proteins 0.000 description 6
- 238000012258 culturing Methods 0.000 description 6
- 230000003247 decreasing effect Effects 0.000 description 6
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 6
- 229930182830 galactose Natural products 0.000 description 6
- 238000001502 gel electrophoresis Methods 0.000 description 6
- 238000010348 incorporation Methods 0.000 description 6
- 230000006698 induction Effects 0.000 description 6
- 239000008188 pellet Substances 0.000 description 6
- 238000012216 screening Methods 0.000 description 6
- 101100246753 Halobacterium salinarum (strain ATCC 700922 / JCM 11081 / NRC-1) pyrF gene Proteins 0.000 description 5
- 101000608772 Homo sapiens Galectin-7 Proteins 0.000 description 5
- 239000000020 Nitrocellulose Substances 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 5
- 108091081024 Start codon Proteins 0.000 description 5
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 5
- 238000000246 agarose gel electrophoresis Methods 0.000 description 5
- 229960005542 ethidium bromide Drugs 0.000 description 5
- 239000000284 extract Substances 0.000 description 5
- 230000003834 intracellular effect Effects 0.000 description 5
- 238000012986 modification Methods 0.000 description 5
- 230000004048 modification Effects 0.000 description 5
- 229920001220 nitrocellulos Polymers 0.000 description 5
- 229910052757 nitrogen Inorganic materials 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 108010025188 Alcohol oxidase Proteins 0.000 description 4
- 108700028369 Alleles Proteins 0.000 description 4
- 108091026890 Coding region Proteins 0.000 description 4
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 4
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 4
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 4
- 108700005078 Synthetic Genes Proteins 0.000 description 4
- 238000005119 centrifugation Methods 0.000 description 4
- 238000004140 cleaning Methods 0.000 description 4
- 238000001962 electrophoresis Methods 0.000 description 4
- 239000013613 expression plasmid Substances 0.000 description 4
- 230000013595 glycosylation Effects 0.000 description 4
- 238000006206 glycosylation reaction Methods 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 235000019419 proteases Nutrition 0.000 description 4
- 230000006798 recombination Effects 0.000 description 4
- 238000005215 recombination Methods 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 238000012546 transfer Methods 0.000 description 4
- 241000283690 Bos taurus Species 0.000 description 3
- 239000003298 DNA probe Substances 0.000 description 3
- 108010093031 Galactosidases Proteins 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 3
- 101150045458 KEX2 gene Proteins 0.000 description 3
- 241000286819 Malo Species 0.000 description 3
- 239000001888 Peptone Substances 0.000 description 3
- 108010080698 Peptones Proteins 0.000 description 3
- 238000002105 Southern blotting Methods 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000003776 cleavage reaction Methods 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 3
- 108091008053 gene clusters Proteins 0.000 description 3
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 238000002955 isolation Methods 0.000 description 3
- 230000007935 neutral effect Effects 0.000 description 3
- 235000019319 peptone Nutrition 0.000 description 3
- 229910052698 phosphorus Inorganic materials 0.000 description 3
- 239000002243 precursor Substances 0.000 description 3
- 230000035755 proliferation Effects 0.000 description 3
- 230000017854 proteolysis Effects 0.000 description 3
- 230000010076 replication Effects 0.000 description 3
- 230000007017 scission Effects 0.000 description 3
- 238000012163 sequencing technique Methods 0.000 description 3
- 231100000167 toxic agent Toxicity 0.000 description 3
- 238000013518 transcription Methods 0.000 description 3
- 230000035897 transcription Effects 0.000 description 3
- 230000001131 transforming effect Effects 0.000 description 3
- 230000014616 translation Effects 0.000 description 3
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 3
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
- 108020005065 3' Flanking Region Proteins 0.000 description 2
- 108020005029 5' Flanking Region Proteins 0.000 description 2
- 239000002028 Biomass Substances 0.000 description 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 108700039887 Essential Genes Proteins 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 102000002464 Galactosidases Human genes 0.000 description 2
- 241000282414 Homo sapiens Species 0.000 description 2
- 101150044356 I2 gene Proteins 0.000 description 2
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 2
- 101150007280 LEU2 gene Proteins 0.000 description 2
- 239000006142 Luria-Bertani Agar Substances 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 108010064851 Plant Proteins Proteins 0.000 description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
- 239000004098 Tetracycline Substances 0.000 description 2
- 108700009124 Transcription Initiation Site Proteins 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 229960000723 ampicillin Drugs 0.000 description 2
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 210000003578 bacterial chromosome Anatomy 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 239000001110 calcium chloride Substances 0.000 description 2
- 229910001628 calcium chloride Inorganic materials 0.000 description 2
- 235000011148 calcium chloride Nutrition 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 230000021615 conjugation Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 230000008451 emotion Effects 0.000 description 2
- 238000012262 fermentative production Methods 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 230000002538 fungal effect Effects 0.000 description 2
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000013028 medium composition Substances 0.000 description 2
- 239000002751 oligonucleotide probe Substances 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 235000021118 plant-derived protein Nutrition 0.000 description 2
- 239000013600 plasmid vector Substances 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 108091033319 polynucleotide Proteins 0.000 description 2
- 102000040430 polynucleotide Human genes 0.000 description 2
- 239000002157 polynucleotide Substances 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000003362 replicative effect Effects 0.000 description 2
- 230000001177 retroviral effect Effects 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
- 239000001488 sodium phosphate Substances 0.000 description 2
- 229910000162 sodium phosphate Inorganic materials 0.000 description 2
- 125000006850 spacer group Chemical group 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 229960002180 tetracycline Drugs 0.000 description 2
- 229930101283 tetracycline Natural products 0.000 description 2
- 235000019364 tetracycline Nutrition 0.000 description 2
- 150000003522 tetracyclines Chemical class 0.000 description 2
- 230000014621 translational initiation Effects 0.000 description 2
- 230000032258 transport Effects 0.000 description 2
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 2
- 239000000052 vinegar Substances 0.000 description 2
- 235000021419 vinegar Nutrition 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 238000001262 western blot Methods 0.000 description 2
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 1
- HOMROMWVNDUGRI-RVZXSAGBSA-N (2s)-2-aminopentanedioic acid;(2s)-2,6-diaminohexanoic acid Chemical compound NCCCC[C@H](N)C(O)=O.OC(=O)[C@@H](N)CCC(O)=O HOMROMWVNDUGRI-RVZXSAGBSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- JTTIOYHBNXDJOD-UHFFFAOYSA-N 2,4,6-triaminopyrimidine Chemical compound NC1=CC(N)=NC(N)=N1 JTTIOYHBNXDJOD-UHFFFAOYSA-N 0.000 description 1
- VUFNLQXQSDUXKB-DOFZRALJSA-N 2-[4-[4-[bis(2-chloroethyl)amino]phenyl]butanoyloxy]ethyl (5z,8z,11z,14z)-icosa-5,8,11,14-tetraenoate Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(=O)OCCOC(=O)CCCC1=CC=C(N(CCCl)CCCl)C=C1 VUFNLQXQSDUXKB-DOFZRALJSA-N 0.000 description 1
- GNFTZDOKVXKIBK-UHFFFAOYSA-N 3-(2-methoxyethoxy)benzohydrazide Chemical compound COCCOC1=CC=CC(C(=O)NN)=C1 GNFTZDOKVXKIBK-UHFFFAOYSA-N 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 241001385733 Aesculus indica Species 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 101500021173 Aplysia californica Myomodulin-E Proteins 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 101000981884 Brevibacillus parabrevis Valine racemase [ATP-hydrolyzing] Proteins 0.000 description 1
- 101100150553 Caenorhabditis elegans ssu-1 gene Proteins 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 102100035882 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 108020004998 Chloroplast DNA Proteins 0.000 description 1
- 108091033380 Coding strand Proteins 0.000 description 1
- 229940126062 Compound A Drugs 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 108020003215 DNA Probes Proteins 0.000 description 1
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108010067770 Endopeptidase K Proteins 0.000 description 1
- 241000701959 Escherichia virus Lambda Species 0.000 description 1
- 240000005708 Eugenia stipitata Species 0.000 description 1
- 235000006149 Eugenia stipitata Nutrition 0.000 description 1
- 101710089384 Extracellular protease Proteins 0.000 description 1
- 108050001049 Extracellular proteins Proteins 0.000 description 1
- 229920001917 Ficoll Polymers 0.000 description 1
- 102100031351 Galectin-9 Human genes 0.000 description 1
- 101710121810 Galectin-9 Proteins 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 101000804764 Homo sapiens Lymphotactin Proteins 0.000 description 1
- 101000724418 Homo sapiens Neutral amino acid transporter B(0) Proteins 0.000 description 1
- 101000701902 Homo sapiens Serpin B4 Proteins 0.000 description 1
- 101000800133 Homo sapiens Thyroglobulin Proteins 0.000 description 1
- 101150017040 I gene Proteins 0.000 description 1
- 108090000769 Isomerases Proteins 0.000 description 1
- 102000004195 Isomerases Human genes 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 241000906091 Lethrinus miniatus Species 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- 102100035304 Lymphotactin Human genes 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 241001365977 Mallos Species 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 240000000982 Malva neglecta Species 0.000 description 1
- 235000000060 Malva neglecta Nutrition 0.000 description 1
- 241000600169 Maro Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 108010006519 Molecular Chaperones Proteins 0.000 description 1
- 102000005431 Molecular Chaperones Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 description 1
- 101000744152 Naja oxiana Cytotoxin 2 Proteins 0.000 description 1
- 102100028267 Neutral amino acid transporter B(0) Human genes 0.000 description 1
- 108010055012 Orotidine-5'-phosphate decarboxylase Proteins 0.000 description 1
- 102220520572 Osteoclast-stimulating factor 1_N48S_mutation Human genes 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 108091000080 Phosphotransferase Proteins 0.000 description 1
- 108010021757 Polynucleotide 5'-Hydroxyl-Kinase Proteins 0.000 description 1
- 102000008422 Polynucleotide 5'-hydroxyl-kinase Human genes 0.000 description 1
- 101710089165 Protein white Proteins 0.000 description 1
- 101000968491 Pseudomonas sp. (strain 109) Triacylglycerol lipase Proteins 0.000 description 1
- 102220511193 Putative nuclease HARBI1_G17S_mutation Human genes 0.000 description 1
- 108020005091 Replication Origin Proteins 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- 102100030326 Serpin B4 Human genes 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 241000784863 Stomatium Species 0.000 description 1
- 101150006914 TRP1 gene Proteins 0.000 description 1
- 102220483321 Thioredoxin-related transmembrane protein 2_D55A_mutation Human genes 0.000 description 1
- 108091023040 Transcription factor Proteins 0.000 description 1
- 102000040945 Transcription factor Human genes 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 208000003822 aplasia of lacrimal and salivary glands Diseases 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 229940009098 aspartate Drugs 0.000 description 1
- 238000000376 autoradiography Methods 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000012888 bovine serum Substances 0.000 description 1
- 102220427817 c.182G>C Human genes 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 239000013599 cloning vector Substances 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000013256 coordination polymer Substances 0.000 description 1
- 239000013601 cosmid vector Substances 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002900 effect on cell Effects 0.000 description 1
- 238000005868 electrolysis reaction Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000012869 ethanol precipitation Methods 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- OPMNROCQHKJDAQ-UHFFFAOYSA-N festucine Natural products C1CC2OC3C(NC)C2N1C3 OPMNROCQHKJDAQ-UHFFFAOYSA-N 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 238000012224 gene deletion Methods 0.000 description 1
- 235000003869 genetically modified organism Nutrition 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 101150085823 hsdR gene Proteins 0.000 description 1
- 102000047688 human TG Human genes 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 125000003473 lipid group Chemical group 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- AVDXUVZURBFCNE-UHFFFAOYSA-N lolin Natural products CC1C(O)C(O)C2(COC(=O)C)C(CCC=C2CO)C13CC(OC3=O)c4cocc4 AVDXUVZURBFCNE-UHFFFAOYSA-N 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 230000007257 malfunction Effects 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 239000006151 minimal media Substances 0.000 description 1
- 230000000394 mitotic effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000002515 oligonucleotide synthesis Methods 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- -1 p[1R6860 Chemical compound 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 102000020233 phosphotransferase Human genes 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 108700003061 poly(glutamic acid-lysine) Proteins 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 125000001500 prolyl group Chemical group [H]N1C([H])(C(=O)[*])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 230000001902 propagating effect Effects 0.000 description 1
- 238000013138 pruning Methods 0.000 description 1
- ZHNFLHYOFXQIOW-LPYZJUEESA-N quinine sulfate dihydrate Chemical compound [H+].[H+].O.O.[O-]S([O-])(=O)=O.C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21.C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21 ZHNFLHYOFXQIOW-LPYZJUEESA-N 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 239000011535 reaction buffer Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000000384 rearing effect Effects 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- 101150079601 recA gene Proteins 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- FCBUKWWQSZQDDI-UHFFFAOYSA-N rhamnolipid Chemical compound CCCCCCCC(CC(O)=O)OC(=O)CC(CCCCCCC)OC1OC(C)C(O)C(O)C1OC1C(O)C(O)C(O)C(C)O1 FCBUKWWQSZQDDI-UHFFFAOYSA-N 0.000 description 1
- 239000007320 rich medium Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000013605 shuttle vector Substances 0.000 description 1
- 230000037432 silent mutation Effects 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 229910021654 trace metal Inorganic materials 0.000 description 1
- 238000001890 transfection Methods 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 230000005945 translocation Effects 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 108700026220 vif Genes Proteins 0.000 description 1
- FEPMHVLSLDOMQC-UHFFFAOYSA-N virginiamycin-S1 Natural products CC1OC(=O)C(C=2C=CC=CC=2)NC(=O)C2CC(=O)CCN2C(=O)C(CC=2C=CC=CC=2)N(C)C(=O)C2CCCN2C(=O)C(CC)NC(=O)C1NC(=O)C1=NC=CC=C1O FEPMHVLSLDOMQC-UHFFFAOYSA-N 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 210000004885 white matter Anatomy 0.000 description 1
- 210000005253 yeast cell Anatomy 0.000 description 1
- 239000007207 ypga Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2465—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1) acting on alpha-galactose-glycoside bonds, e.g. alpha-galactosidase (3.2.1.22)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
- C12N15/815—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/18—Carboxylic ester hydrolases (3.1.1)
- C12N9/20—Triglyceride splitting, e.g. by means of lipase
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
Claims (27)
- 1.宿主真核生物のゲノムに発現ベクターをマルチコピー組込みして形質転換し た真核生物により同種または異種の蛋白質を製造する方法であって、前記発現ベ クターは本明細書に定義の、前記同種または異種の蛋白質をコードする「発現可 能な遺伝子」と本明細書に定義の「特定培地中での酵母またはかびの増殖に必要 な欠失選択マーカー」の両方を含有しており、前記発現ベクターは、真核生物ゲ ノムのリボソームDNA遺伝子座への前記発現ベクターのマルチコピー組込みを 可能にするリボソームDNA配列を含有している該方法。
- 2.前記欠失選択マーカーをLEU2d遺伝子、TRP1d遺伝子及びURA3 d連伝子からなる群から選択する請求の範囲第1項の方法。
- 3.真核生物が真菌である請求の範囲第1項の方法。
- 4.真菌が、好ましくはSaccharomyces、Kluyveromyc es及びHaosemul2属からなる群から選択した酵母、または好ましくは Aspergillus、Rhisopus及びTrichoderma属から なる群から選択したかびである請求の範囲第3項の方法。
- 5.前記形質転換した真核生物を、真核生物の増殖に必須の成分を、この成分の 取り込みが律速的である濃度で含有している培地で培養し、従って、宿主生物及 び反応条件によって異なるある最小値以上の増殖速度を得るためには前記成分の 新規の合成が必要となる請求の範囲第1項の方法。
- 6.形質転換した真核生物を、真核生物の増殖に必要な全ての成分を含有してい る、いわゆる「完全」または非選択的培地で培養する請求の範囲第5項の方法。
- 7.完全培地が、好ましくは糖蜜、乳漿、酵母抽出物及びそれらの混合物からな る群から選択した工業用に使用される増殖培地である請求の範囲第6項の方法。
- 8.形質転換した真核生物が、リボソームRNAをコードする遺伝子座にあるま たは直接結合している染色体の1つに、マルチメリックな形で、前記蛋白質を発 現するために必要な遺伝子を含有し、同時に、同じ遺伝子座に前記「必須栄養素 」の合成に生化学経路で必要な蛋白質をコードする欠失遺伝子のマルチコピーも 存在する請求の範囲第1項の方法。
- 9.発現可能な遺伝子が酵素、好ましくは加水分解酵素、特にリパーゼまたは遺 伝子学的に修飾したこのような遺伝子をコードする請求の範囲第8項の方法。
- 10.リパーゼを、Chromobacte viscom var lipo lyticomNRRL B−3673 由来のリパーゼに対する抗血清と交差 反応性のあるリパーゼ、Alcaligenes PL−679、ATCC31 371またはFERM−P3783由来のリパーゼに対する抗血清と交差反応す るリパーゼ、Pseudomonas fluorescens IAM 10 57由来のリパーゼに対する抗血清と交差反応するリパーゼ及びこれらの交差反 応性リパーゼの修飾型からなる群から選択する請求の範囲第9項の方法。
- 11.第2図に示すヌクレオチド配列またはそのヌクレオチド配列で特定される 同じアミノ酸配列もしくは元のリパーゼと比べて洗剤系で全体的な性能が改良さ れたりパーゼが得られるような修飾型のこのアミノ酸配列をコードする任意のヌ クレオチド配列を有する遺伝子でリパーゼがコードされる請求の範囲第9項の方 法。
- 12.真核生物が本明細書に定義のような「必須栄養素」の合成を欠失しており 、従って、欠失選択マーカーが「必須栄養素」の合成の相補に寄与しうる請求の 範囲第1項の方法。
- 13.前記必須栄養素を製造する生合成経路に有効な酸素をコードする遺伝子を 置換して親株を欠失させる請求の範囲第12項の方法。
- 14.親株が欠失している酵素が、必須栄養素が形成されるまで分岐しない生合 成経路の一部の反応を触媒する請求の範囲第13項の方法。
- 15.必須栄養素がアミノ酸、ヌクレオチドまたはビタミン、特にアミノ酸のロ イシン、 トリプトファンまたはウラシルの1つである請求の範囲第12項の方 法。
- 16.発現ベクターが、ベクターに通常存在する配列の他に、(i) dsリボ ソームDNAまたはその一部例えばリボソームRNAをコードするdsDNA配 列、及び(ii)5′−−−>3′の方向に次の順序で:(ii)(a)宿主生 物中で作動可能な強力プロモーター、(ii)(b)任意に、宿主真核生物から の前記蛋白質の分泌を促進させるシグナル配列、 (ii) (c) 蛋白質をコードする構造遺伝子、(ii)(d)宿主真核生 物で作動可能な有効なターミネーターを含有しているDNA配列 を含有している請求の範囲第1項の方法。
- 17.リボソームDNAを、かび特にAspergillus、Rhizopu s及びTrichoderma属のかび、及び酵母特にSaccharomyc es、Kluyveromyces、Hansenula及びPichia属の 酵母にあるリボソームDNAからなる群から選択することを特徴とする請求の範 囲第16項の方法。
- 18.ベクターが宿主生物の1つのリボソームDNA単位とほぼ同じ長さである 請求の範囲第16項の方法。
- 19.プロモーターを、 (i)宿主がSaccharomyces属に属するときには、Gal7プロモ ーター、GAPDHプロモーターまたはPGKプロモーター、(ii)宿主がK luyveromyces属に属するときには、イヌリナーゼプロモーター、P GKプロモーターまたはLAC4プロモーター、(iii) 宿主がHanse nula属に属するときには、DHASプロモーターまたはMOXプロモーター 、 (iv) 宿主がAspergifiug属のかびに属するときには、グルコア ミラーゼプロモーター、グルコースオキシダーゼプロモーターまたはGAPDH プロモーター、 (v)宿主がRbizopus及びtrichoderma属のかびに属すると きには、セルラーゼプロモーターまたはGAPDHプロモーターからなる群から 選択する請求の範囲第16項の方法。
- 20.蛋白質がオキシダーゼであり、宿主細胞がHansenulaまたはpi chiaまたはAspergillus属に属する請求の範囲第19項の方法。
- 21.蛋白質をコードする構造遺伝子が免疫グロブリンのL鎖またはH鎖、また は好ましくは両方、または免疫グロブリンのL鎖またはH鎖の一部、好ましくは 通常FABフラグメントと呼ばれる部分、または可変部をコードする請求の範囲 第16項の方法。
- 22.遺伝子を遺伝子工学処理により修飾して、修飾免疫グロブリンまたは触媒 活性を有する免疫グロブリン(アブザイム)が得られる請求の範囲第21項の方 法。
- 23.発現ベクターがさらに宿主細胞染色体から欠失または破壊された酵素をコ ードする欠失遺伝子を含有する請求の範囲第16項の方法。
- 24.欠失遺伝子が必須栄養素例えばロイシン、トリブトファンのようなアミノ 酸またはウラシル、ヌクレオチドまたはビタミンを製造する生合成経路に有効な 酸素をコードする請求の範囲第23項の方法。
- 25.方法を、通常のパッチ式発酵、フェッドーバッチ式発酵及び連続発酵から なる群から選択する請求の範囲第1項の方法。
- 26.培地が、染色体内に少なくとも20好ましくは少なくとも50コピーの欠 失遺伝子が維持される濃度で必須栄養素を含有しており、前記欠失遺伝子が必須 栄養素の生合成に関与する酵素をコードする請求の範囲第25項の方法。
- 27.宿主の増殖速度が、同じ発酵条件下の、必須栄養素を欠失していない同様 な宿主の最高増殖速度の20〜100%、好ましくは80〜100%であること を特徴とする請求の範囲第26項の方法。
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB898915659A GB8915659D0 (en) | 1989-07-07 | 1989-07-07 | Enzymes,their production and use |
GB8915659.0 | 1989-07-07 | ||
NL90201007.3 | 1990-04-20 | ||
NL8915659.0 | 1990-04-20 | ||
EP90201007 | 1990-04-20 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH05501949A true JPH05501949A (ja) | 1993-04-15 |
JP3273609B2 JP3273609B2 (ja) | 2002-04-08 |
Family
ID=26125849
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP51119190A Expired - Fee Related JP3273609B2 (ja) | 1989-07-07 | 1990-07-09 | 発現ベクターのマルチコピー組込みにより形質転換した真菌による蛋白質の製法 |
Country Status (10)
Country | Link |
---|---|
US (1) | US6090574A (ja) |
EP (2) | EP0778348B1 (ja) |
JP (1) | JP3273609B2 (ja) |
AT (2) | ATE196505T1 (ja) |
CA (1) | CA2063592C (ja) |
DE (2) | DE69033633T2 (ja) |
DK (2) | DK0778348T3 (ja) |
ES (2) | ES2109238T3 (ja) |
IE (1) | IE81016B1 (ja) |
WO (1) | WO1991000920A2 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002514077A (ja) * | 1997-04-11 | 2002-05-14 | デーエスエム ナムローゼ フェンノートシャップ | 1を超える非リボソームrnaをコードしているドメインの染色体ゲノムに組込まれた少なくとも2コピーの所望遺伝子を含む、特にクルイベロミセスによる酵母細胞 |
Families Citing this family (105)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991014781A1 (en) * | 1990-03-19 | 1991-10-03 | Henkel Research Corporation | METHOD FOR INCREASING THE OMEGA-HYDROXYLASE ACTIVITY IN $i(CANDIDA TROPICALIS) |
ATE140974T1 (de) * | 1990-10-04 | 1996-08-15 | Japan Maize Prod | Wirt-vektor-system |
JP3133774B2 (ja) * | 1990-10-04 | 2001-02-13 | 日本食品化工株式会社 | 新規な宿主−ベクター系 |
IT1251435B (it) * | 1991-09-04 | 1995-05-09 | Sclavo Spa | Vettore genetico per la integrazione multipla stabile di sequenze di dna nel genoma dei lieviti kluyveromyces lactis e saccharomyces cerevisiae e plasmidi che lo contengono. |
WO1994013821A1 (en) * | 1992-12-11 | 1994-06-23 | Quest International B.V. | The use of the kluyveromyces marxianus inulinase gene promoter for protein production |
JPH08508892A (ja) * | 1993-09-02 | 1996-09-24 | ファイザー・インク. | 多重組込みベクター及びヤロウィア・リポリティカ形質転換体 |
US6936289B2 (en) | 1995-06-07 | 2005-08-30 | Danisco A/S | Method of improving the properties of a flour dough, a flour dough improving composition and improved food products |
EP0932691A1 (en) * | 1996-09-24 | 1999-08-04 | Plant Genetic Systems N.V. | Dna-constructs comprising intergenic ribosomal dna and methods to produce proteins using these dna-constructs |
US7883872B2 (en) | 1996-10-10 | 2011-02-08 | Dyadic International (Usa), Inc. | Construction of highly efficient cellulase compositions for enzymatic hydrolysis of cellulose |
JP4307563B2 (ja) | 1997-04-07 | 2009-08-05 | ユニリーバー・ナームローゼ・ベンノートシャープ | 糸状菌、特にアスペルギルス属に属する糸状菌のアグロバクテリウム媒介性形質転換 |
EP0870835A1 (en) * | 1997-04-07 | 1998-10-14 | Unilever N.V. | Agrobacterium mediated transformation of moulds, in particular those belonging to the genus Aspergillus |
EP1559788A1 (en) | 1997-04-09 | 2005-08-03 | Danisco A/S | Use lipase for improving doughs and baked products |
EP0979294B1 (en) | 1997-04-11 | 2015-05-27 | DSM IP Assets B.V. | Gene conversion as a tool for the construction of recombinant industrial filamentous fungi |
US6265186B1 (en) | 1997-04-11 | 2001-07-24 | Dsm N.V. | Yeast cells comprising at least two copies of a desired gene integrated into the chromosomal genome at more than one non-ribosomal RNA encoding domain, particularly with Kluyveromyces |
AU734761B2 (en) * | 1997-05-27 | 2001-06-21 | Hanil Synthetic Fiber Co., Ltd. | Process for preparing recombinant proteins using highly efficient expression vector from saccharomyces cerevisiae |
US6228583B1 (en) * | 1997-08-04 | 2001-05-08 | Massachusetts Institute Of Technology | Assays for compounds which extend life span |
ES2287989T3 (es) * | 1997-12-22 | 2007-12-16 | Dsm Ip Assets B.V. | Clonacion de expresion en hongos filamentosos. |
US6436643B1 (en) | 1997-12-22 | 2002-08-20 | Unilever Patent Holdings Bv | Process for site-directed integration of multiple copies of a gene in a mould |
EP1073755A2 (en) * | 1998-04-28 | 2001-02-07 | Axys Pharmaceuticals, Inc. | Novel serine protease capable of selective cleavage of insulin-like growth factor binding protein |
CN1230546C (zh) | 1998-10-06 | 2005-12-07 | 马克·阿龙·埃马尔法尔布 | 丝状真菌宿主领域的转化系统 |
US7220542B2 (en) | 2000-07-17 | 2007-05-22 | Van Den Brink Johannes Maarten | Expression cloning in filamentous fungi |
WO2001020007A1 (en) * | 1999-09-13 | 2001-03-22 | Concordia University | A multifunctional system for the efficient manipulation of protein expression in filamentous fungi and method using same |
DE19963690A1 (de) * | 1999-11-23 | 2001-06-13 | Rhein Biotech Proz & Prod Gmbh | Vektoren und Verfahren zur Herstellung rekombinanter Proteine in Pilzen |
CN1524120A (zh) * | 2000-11-15 | 2004-08-25 | 凯敏工业公司 | 超量产酶的转基因微生物 |
IL156438A0 (en) | 2000-12-13 | 2004-01-04 | Unilever Plc | Method for the production of a heterologous protein by a fungus |
WO2002059330A2 (en) * | 2001-01-25 | 2002-08-01 | Evolva Biotech A/S | Artificial chromosomes comprising concatemers of expressible nucleotide sequences |
US7838287B2 (en) | 2001-01-25 | 2010-11-23 | Evolva Sa | Library of a collection of cells |
NZ528260A (en) | 2001-05-18 | 2005-09-30 | Danisco | Method of improving dough and bread quality with the addition of an enzyme that hydrolyses a glycolipid and a phospholipid and incapable of hydrolysing a triglyceride or monoglyceride |
ITMI20011728A1 (it) * | 2001-08-06 | 2003-02-06 | Consorzio Per Le Ricerche E Lo | Vettore per l'integrazione sito-specifica di sequenze di dna eterologhe in lieviti metilotrofi |
MXPA05007654A (es) | 2003-01-17 | 2005-09-30 | Danisco | Metodo. |
WO2004072225A2 (en) * | 2003-02-12 | 2004-08-26 | Ramot At Tel Aviv University Ltd. | Transgenic fungi expressing bcl-2 and methods of using bcl-2 or portions thereof for improving biomass production, survival, longevity, stress resistance and pathogenicity of fungi |
GB0405637D0 (en) | 2004-03-12 | 2004-04-21 | Danisco | Protein |
CA2572843A1 (en) | 2004-07-16 | 2006-01-26 | Danisco A/S | Lipolytic enzyme uses thereof in the food industry |
WO2008073914A2 (en) | 2006-12-10 | 2008-06-19 | Dyadic International Inc. | Expression and high-throughput screening of complex expressed dna libraries in filamentous fungi |
EP2197893B1 (en) | 2007-09-07 | 2013-07-24 | Dyadic International, Inc. | Novel fungal enzymes |
ATE555203T1 (de) | 2007-11-20 | 2012-05-15 | Dsm Ip Assets Bv | Dicarbonsäureproduktion in eukaryonten |
WO2009065779A1 (en) | 2007-11-20 | 2009-05-28 | Dsm Ip Assets B.V. | Dicarboxylic acid production in a recombinant yeast |
US20110318795A1 (en) | 2007-11-20 | 2011-12-29 | Verwaal Rene | Dicarboxylic acid production in a filamentous fungus |
EP2116136A1 (en) | 2008-05-08 | 2009-11-11 | Nederlandse Organisatie voor toegepast- natuurwetenschappelijk onderzoek TNO | Novel phytases |
MY161855A (en) * | 2008-10-03 | 2017-05-15 | Agrisoma Biosciences Inc | Production of modified fatty acids in plants through rdna targeted integration of heterologous genes |
US8735100B2 (en) | 2009-03-17 | 2014-05-27 | Nederlandse Organisatie Voor Toegepast -Natuurwetenschappelijk Onderzoek Tno | Cellulose and ligno-cellulose active proteins |
WO2010118932A1 (en) | 2009-04-15 | 2010-10-21 | Dsm Ip Assets B.V. | Dicarboxylic acid production process |
RU2439157C2 (ru) * | 2009-06-18 | 2012-01-10 | Федеральное государственное унитарное предприятие "Государственный научно-исследовательский институт генетики и селекции промышленных микроорганизмов" (ФГУП ГосНИИгенетика) | ГЕНЕТИЧЕСКАЯ КОНСТРУКЦИЯ ДЛЯ ПОЛУЧЕНИЯ СТАБИЛЬНЫХ ТРАНСФОРМАНТОВ ГРИБОВ РОДА Rhizopus |
UA108853C2 (uk) | 2009-07-10 | 2015-06-25 | Спосіб ферментації галактози | |
DE102009035671A1 (de) * | 2009-07-30 | 2011-02-03 | Dechema Gesellschaft Für Chemische Technik Und Biotechnologie E.V. | Verfahren zur Expression von homologen Proteinen und/oder Peptiden in Pilzen der Klasse Dothideomycetes |
RU2420567C1 (ru) * | 2009-12-09 | 2011-06-10 | Федеральное государственное унитарное предприятие "Государственный научно-исследовательский институт генетики и селекции промышленных микроорганизмов" (ФГУП ГосНИИгенетика) | СПОСОБ КОНСТРУИРОВАНИЯ ШТАММОВ ДРОЖЖЕЙ Saccharomyces cerevisiae - СТАБИЛЬНЫХ ПРОДУЦЕНТОВ СОМАТОТРОПИНА ЧЕЛОВЕКА, ШТАММ ДРОЖЖЕЙ Saccharomyces cerevisiae - СТАБИЛЬНЫЙ ПРОДУЦЕНТ СОМАТОТРОПИНА ЧЕЛОВЕКА (ВАРИАНТЫ) |
EP2560988A1 (en) | 2010-04-21 | 2013-02-27 | DSM IP Assets B.V. | Process for the production of cells which are capable of converting arabinose |
EP2388331A1 (en) | 2010-05-21 | 2011-11-23 | Nederlandse Organisatie voor toegepast -natuurwetenschappelijk onderzoek TNO | Constitutive promoter |
EP2627767A1 (en) | 2010-10-13 | 2013-08-21 | DSM IP Assets B.V. | Polypeptides with permease activity |
EA201301193A1 (ru) | 2011-04-22 | 2014-02-28 | ДСМ АйПи АССЕТС Б.В. | Дрожжевые клетки, способные к превращению сахаров, содержащих арабинозу и ксилозу |
EP2554668A1 (en) | 2011-08-04 | 2013-02-06 | DSM IP Assets B.V. | A pentose sugar fermenting cell |
AR087423A1 (es) | 2011-08-04 | 2014-03-19 | Dsm Ip Assets Bv | Celula capaz de fermentar azucares pentosas |
EP2806754B1 (en) | 2012-01-23 | 2018-10-24 | DSM IP Assets B.V. | Diterpene production |
US20130273619A1 (en) | 2012-04-16 | 2013-10-17 | Basf Se | Process for the Preparation of (3E, 7E)-Homofarnesol |
WO2014060377A1 (en) | 2012-10-16 | 2014-04-24 | Dsm Ip Assets B.V. | Cells with improved pentose conversion |
EP2772545A1 (en) | 2013-03-01 | 2014-09-03 | Nederlandse Organisatie voor toegepast -natuurwetenschappelijk onderzoek TNO | Starch active proteins |
CN105431539B (zh) | 2013-05-02 | 2021-05-25 | 乐斯福公司 | 新的有机酸通路 |
CN105452476B (zh) | 2013-05-31 | 2020-08-14 | 帝斯曼知识产权资产管理有限公司 | 用于二萜生产的微生物 |
CN108064135A (zh) | 2013-07-15 | 2018-05-22 | 帝斯曼知识产权资产管理有限公司 | 二萜的生产 |
CA2917699C (en) | 2013-07-31 | 2021-12-07 | Dsm Ip Assets B.V. | Recovery of steviol glycosides |
EP3259361A1 (en) | 2015-02-16 | 2017-12-27 | DSM IP Assets B.V. | Process for producing itaconic acid under anaerobic conditions |
BR112017021066B1 (pt) | 2015-04-03 | 2022-02-08 | Dsm Ip Assets B.V. | Glicosídeos de esteviol, método para a produção de um glicosídeo de esteviol, composição, usos relacionados, gênero alimentício, alimento para animais e bebida |
WO2016170045A1 (en) | 2015-04-21 | 2016-10-27 | Dsm Ip Assets B.V. | Geranylgeranyl pyrophosphate synthase |
CN107636144B (zh) | 2015-05-22 | 2021-02-19 | 帝斯曼知识产权资产管理有限公司 | 消耗乙酸盐/酯的酵母细胞 |
MY192153A (en) | 2015-07-10 | 2022-08-02 | Dsm Ip Assets Bv | Steviol glycoside composition |
WO2017025649A1 (en) | 2015-08-13 | 2017-02-16 | Dsm Ip Assets B.V. | Steviol glycoside transport |
WO2017050652A1 (en) | 2015-09-25 | 2017-03-30 | Dsm Ip Assets B.V. | Asparaginase |
MY186400A (en) | 2015-10-06 | 2021-07-22 | Dsm Ip Assets Bv | Eukaryotic cell with increased production of fermentation product |
EP3435772A1 (en) | 2016-03-31 | 2019-02-06 | DSM IP Assets B.V. | Enzyme composition and preparation of a dairy product with improved properties |
WO2017167847A1 (en) | 2016-03-31 | 2017-10-05 | Dsm Ip Assets B.V. | Production of milk with low lactose content |
EP3435771A1 (en) | 2016-03-31 | 2019-02-06 | DSM IP Assets B.V. | Enzyme composition and preparation of a dairy product with improved properties |
WO2017216136A1 (en) | 2016-06-14 | 2017-12-21 | Dsm Ip Assets B.V. | Recombinant yeast cell |
CA3030605A1 (en) | 2016-07-13 | 2018-01-18 | Dsm Ip Assets B.V. | Malate dehyrogenases |
CA3033243A1 (en) | 2016-08-09 | 2018-02-15 | Dsm Ip Assets B.V. | Crystallization of steviol glycosides |
CA3032656A1 (en) | 2016-08-09 | 2018-02-15 | Dsm Ip Assets B.V. | Crystallization of steviol glycosides |
CN110036114B (zh) | 2016-08-26 | 2023-09-29 | 勒萨弗尔公司 | 提高的衣康酸生产 |
WO2018073107A1 (en) | 2016-10-19 | 2018-04-26 | Dsm Ip Assets B.V. | Eukaryotic cell comprising xylose isomerase |
WO2018114938A1 (en) | 2016-12-21 | 2018-06-28 | Dsm Ip Assets B.V. | Lipolytic enzyme variants |
BR112019012559A2 (pt) | 2016-12-21 | 2019-11-26 | Dsm Ip Assets Bv | variantes de enzima lipolítica |
WO2018114912A1 (en) | 2016-12-21 | 2018-06-28 | Dsm Ip Assets B.V. | Lipolytic enzyme variants |
US10918113B2 (en) | 2016-12-21 | 2021-02-16 | Dsm Ip Assets B.V. | Lipolytic enzyme variants |
WO2018114995A1 (en) | 2016-12-22 | 2018-06-28 | Dsm Ip Assets B.V. | Fermentation process for producing steviol glycosides |
US11667886B2 (en) | 2017-06-13 | 2023-06-06 | Dsm Ip Assets B.V. | Recombinant yeast cell |
CA3068459A1 (en) * | 2017-06-30 | 2019-01-03 | Ptt Global Chemical Public Company Limited | Microorganism with stabilized copy number of functional dna sequence and associated methods |
BR112020004921A2 (pt) | 2017-09-26 | 2020-09-15 | Dsm Ip Assets B.V. | cepa consumidora de ácido acético |
EP3533878A1 (en) | 2018-02-28 | 2019-09-04 | Dutch DNA Biotech B.V. | Process for producing citramalic acid employing aspergillus |
CN112292037B (zh) | 2018-06-19 | 2024-03-22 | 帝斯曼知识产权资产管理有限公司 | 脂解酶变体 |
CN111254127B (zh) * | 2018-11-30 | 2022-06-10 | 康码(上海)生物科技有限公司 | 蛋白激酶a催化亚基tpk2基因改造方法及其应用 |
CN111254128A (zh) * | 2018-11-30 | 2020-06-09 | 康码(上海)生物科技有限公司 | 蛋白激酶a催化亚基tpk1基因改造方法及其应用 |
WO2022084482A1 (en) | 2020-10-22 | 2022-04-28 | Dsm Ip Assets B.V. | Microorganisms for diterpene production |
FR3122436B1 (fr) * | 2021-04-30 | 2025-04-11 | Ifp Energies Now | Insertion multicopies d’un gène d’intérêt dans le génome d’un champignon |
WO2022269549A2 (en) | 2021-06-24 | 2022-12-29 | Fonterra Co-Operative Group Limited | Recombinant proteins |
MX2024000606A (es) | 2021-07-12 | 2024-01-30 | Danisco Us Inc | Celula de levadura recombinante. |
MX2024000511A (es) | 2021-07-12 | 2024-03-11 | Danisco Us Inc | Celula de levadura recombinante. |
US20240401088A1 (en) | 2021-07-12 | 2024-12-05 | Danisco Us Inc. | Recombinant yeast cell |
WO2023285280A1 (en) | 2021-07-12 | 2023-01-19 | Dsm Ip Assets B.V. | Recombinant yeast cell |
CN117916381A (zh) | 2021-07-12 | 2024-04-19 | 丹尼斯科美国公司 | 重组酵母细胞 |
MX2024000515A (es) | 2021-07-12 | 2024-03-11 | Danisco Us Inc | Celula de levadura recombinante. |
CN113564206B (zh) * | 2021-07-29 | 2023-09-26 | 山东大学 | 一种目的基因多拷贝整合到酿酒酵母染色体rDNA的方法 |
MX2024005283A (es) | 2021-11-04 | 2024-05-17 | Danisco Us Inc | Variante de polipeptido y celula de levadura recombinante. |
EP4426848A1 (en) | 2021-11-04 | 2024-09-11 | Danisco Us Inc | Process for the production of ethanol and recombinant yeast cell |
MX2024005281A (es) | 2021-11-04 | 2024-05-17 | Danisco Us Inc | Celula de levadura recombinante. |
TW202325853A (zh) | 2021-11-09 | 2023-07-01 | 美商安進公司 | 治療性蛋白之生產 |
EP4525626A1 (en) | 2022-05-16 | 2025-03-26 | DSM IP Assets B.V. | Lipolytic enzyme variants |
WO2025012325A1 (en) | 2023-07-11 | 2025-01-16 | Dsm Ip Assets B.V. | Protein arginine deiminase |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU600885B2 (en) * | 1984-05-25 | 1990-08-30 | Zymogenetics Inc. | Stable DNA constructs |
GB8415186D0 (en) * | 1984-06-14 | 1984-07-18 | Ciba Geigy Ag | Polypeptides |
EP0173378B1 (en) * | 1984-07-27 | 1991-06-12 | Unilever N.V. | Process for preparing a polypeptide by culturing a transformed microorganism, a transformed microorganism suitable therefor and dna sequences suitable for preparing such microorganism |
JPS61134325A (ja) * | 1984-12-04 | 1986-06-21 | Teijin Ltd | ハイブリツド抗体遺伝子の発現方法 |
JPH0614865B2 (ja) * | 1985-12-13 | 1994-03-02 | 麒麟麦酒株式会社 | α―アセト乳酸脱炭酸酵素をコードするDNA鎖およびこのDNA鎖により形質転換された酵母 |
WO1987007461A1 (en) | 1986-05-28 | 1987-12-03 | Mitsubishi Denki Kabushiki Kaisha | Image reproducing apparatus |
CA1339101C (en) * | 1986-06-03 | 1997-07-29 | Nicolaas Overbeeke | Production of guar alpha-galactosidase and immunologically related alpha-galactosidases by host organisms transformed with recombinant dna methods |
GB8629536D0 (en) | 1986-12-10 | 1987-01-21 | Unilever Plc | Enzymatic detergent composition |
PT88556B (pt) * | 1987-09-28 | 1992-11-30 | Smithkline Biolog | Processo de integracao genomica estavel e de expressao de uma sequencia de cadificacao estranha, em leveduras |
DK571587D0 (da) | 1987-11-02 | 1987-11-02 | Novo Industri As | Enzymatisk detergentsammensaetning |
DE3887656T2 (de) * | 1987-12-03 | 1994-06-16 | Chisso Corp | Lipasegen. |
US5001230A (en) * | 1988-02-18 | 1991-03-19 | Schering Corporation | T cell activation markers |
JP3079276B2 (ja) * | 1988-02-28 | 2000-08-21 | 天野製薬株式会社 | 組換え体dna、それを含むシュードモナス属菌及びそれを用いたリパーゼの製造法 |
JP2639677B2 (ja) * | 1988-03-14 | 1997-08-13 | 旭化成工業株式会社 | リパーゼの遺伝情報を有するdna |
-
1990
- 1990-07-09 ES ES90911878T patent/ES2109238T3/es not_active Expired - Lifetime
- 1990-07-09 DK DK97200631T patent/DK0778348T3/da active
- 1990-07-09 CA CA002063592A patent/CA2063592C/en not_active Expired - Lifetime
- 1990-07-09 ES ES97200631T patent/ES2150188T3/es not_active Expired - Lifetime
- 1990-07-09 AT AT97200631T patent/ATE196505T1/de not_active IP Right Cessation
- 1990-07-09 DK DK90911878.8T patent/DK0481008T3/da active
- 1990-07-09 IE IE249690A patent/IE81016B1/en not_active IP Right Cessation
- 1990-07-09 AT AT90911878T patent/ATE160176T1/de not_active IP Right Cessation
- 1990-07-09 JP JP51119190A patent/JP3273609B2/ja not_active Expired - Fee Related
- 1990-07-09 EP EP97200631A patent/EP0778348B1/en not_active Expired - Lifetime
- 1990-07-09 WO PCT/EP1990/001138 patent/WO1991000920A2/en active IP Right Grant
- 1990-07-09 DE DE69033633T patent/DE69033633T2/de not_active Expired - Lifetime
- 1990-07-09 DE DE69031710T patent/DE69031710T2/de not_active Expired - Lifetime
- 1990-07-09 EP EP90911878A patent/EP0481008B1/en not_active Expired - Lifetime
-
1994
- 1994-12-27 US US08/364,010 patent/US6090574A/en not_active Expired - Lifetime
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002514077A (ja) * | 1997-04-11 | 2002-05-14 | デーエスエム ナムローゼ フェンノートシャップ | 1を超える非リボソームrnaをコードしているドメインの染色体ゲノムに組込まれた少なくとも2コピーの所望遺伝子を含む、特にクルイベロミセスによる酵母細胞 |
Also Published As
Publication number | Publication date |
---|---|
EP0778348A1 (en) | 1997-06-11 |
DE69033633D1 (de) | 2000-10-26 |
DE69031710D1 (de) | 1997-12-18 |
DE69031710T2 (de) | 1998-03-05 |
ES2150188T3 (es) | 2000-11-16 |
DE69033633T2 (de) | 2001-05-03 |
CA2063592A1 (en) | 1991-01-08 |
EP0481008A1 (en) | 1992-04-22 |
US6090574A (en) | 2000-07-18 |
DK0481008T3 (da) | 1998-05-04 |
JP3273609B2 (ja) | 2002-04-08 |
IE81016B1 (en) | 1999-09-22 |
ATE196505T1 (de) | 2000-10-15 |
ES2109238T3 (es) | 1998-01-16 |
ATE160176T1 (de) | 1997-11-15 |
WO1991000920A2 (en) | 1991-01-24 |
CA2063592C (en) | 2003-01-21 |
EP0778348B1 (en) | 2000-09-20 |
DK0778348T3 (da) | 2000-12-04 |
EP0481008B1 (en) | 1997-11-12 |
IE902496A1 (en) | 1991-02-13 |
WO1991000920A3 (en) | 1991-03-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH05501949A (ja) | 発現ベクターのマルチコピー組込みにより形質転換した真菌による蛋白質の製法 | |
CN111378585B (zh) | 用于表达外源基因的毕赤酵母突变株 | |
DK2250270T3 (en) | Method for Targeted Integration of Multiple Copies of an Interesting Gene into a Yarrowia Strain | |
EP0438200B1 (en) | Method for the expression of heterologous genes in the yeast Pichia pastoris, expression vectors and transformed microorganisms | |
JPH04507346A (ja) | アルカリ性タンパク質分解酵素およびその製造方法 | |
WO1983004051A1 (en) | Expression of preprothaumatin-like proteins in kluyveromyces yeasts | |
FI105484B (fi) | Pektiinilyaasin ilmentämisjärjestelmää koodittava yhdistelmä-DNA-molekyyli | |
HK1053145A1 (en) | Cloning and expressing an acid-resistant extracellular lipase of yarrowia lipolytica | |
EP0399455B1 (en) | Stably transformed yeast host cells and their use for the production of albumin | |
WO1999032641A1 (en) | A process for site-directed integration of multiple copies of a gene in a mould | |
EP0665890B1 (en) | Increased production of secreted proteins by recombinant eukaryotic cells | |
US6004776A (en) | Process for preparing a protein by a fungus transformed by multicopy integration of an expression vector | |
WO1994008024A9 (en) | Increased production of secreted proteins by recombinant eukaryotic cells | |
JP2003505085A (ja) | Pyrf遺伝子及びその使用 | |
EP0994955B1 (en) | Increased production of secreted proteins by recombinant yeast cells | |
AU2020389348A1 (en) | Non-viral transcription activation domains and methods and uses related thereto | |
KR20080098298A (ko) | 야로위아 리폴리티카 유래의 신규 YlMPO1 유전자 및이의 파쇄 균주를 이용한 만노스 인산이 제거된 당단백질생산 방법 | |
JP2000125859A (ja) | 新規な選択マーカー遺伝子ならびにリゾムコール・プシルスの形質転換系 | |
IE19980989A1 (en) | Process for preparing a protein by a fungus transformed by multicopy integration of an expression vector | |
IE83463B1 (en) | Process for preparing a protein by a fungus transformed by multicopy integration of an expression vector |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080201 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090201 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090201 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100201 Year of fee payment: 8 |
|
LAPS | Cancellation because of no payment of annual fees |